Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a <scp>52‐week</scp> phase 3 open‐label study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Final analysis of a 52‐week phase 3 open‐label study

Published:2022-03-03 Issue:5 Volume:49 Page:479-487
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Yamasaki Kenshi¹^ORCID,Yamanaka Keiichi²^ORCID,Zhao Yiwei³,Iwano Shunsuke⁴,Takei Keiko⁴,Suzuki Koji⁴,Yamamoto Toshiyuki⁵^ORCID

Affiliation:

1. Department of Dermatology Tohoku University Graduate School of Medicine Sendai Japan

2. Department of Dermatology Mie University Graduate School of Medicine Tsu Japan

3. AbbVie Inc. Cambridge Massachusetts USA

4. AbbVie GK Tokyo Japan

5. Department of Dermatology Fukushima Medical University Fukushima Japan

Funder

AbbVie

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.16337

Reference19 articles.

1. Pyoderma gangrenosum: an updated review

2. Pyoderma gangrenosum: challenges and solutions

3. Etiology and Management of Pyoderma Gangrenosum

4. Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment

5. Adalimumab Treatment for Pyoderma Gangrenosum

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medikamentöse Therapien des Ulcus cruris;Aktuelle Dermatologie;2024-06-21

2. Current prescribing for pyoderma gangrenosum in the UK and access to biologic medications: results from a UK Dermatology Clinical Trials Network survey of dermatologists;Clinical and Experimental Dermatology;2024-04-25

3. The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives;International Journal of Molecular Sciences;2024-02-19

4. Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum (PG) in Clinical Trials: A Delphi Consensus on Behalf of the Understanding PG: Review and Assessment of Disease Effects (UPGRADE) Group;Journal of Investigative Dermatology;2023-12

5. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review;The Journal of Dermatology;2023-11-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3